Asgard Therapeutics

About:

Asgard Therapeutics is a Biotechnology Company.

Website: http://www.asgardthx.com/

Top Investors: Novo Holdings, Boehringer Ingelheim Venture Fund, Johnson & Johnson Innovation – JJDC, Industrifonden, RV Invest

Description:

Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biological properties of professional antigen-presenting cells.

Total Funding Amount:

36M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lund, Skane Lan, Sweden

Founded Date:

2018-01-01

Founders:

Cristiana Pires, Filipe Pereira, Fábio Rosa

Number of Employees:

1-10

Last Funding Date:

2024-03-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai